Metformin and its Liver Targets in the Treatment of Type 2 Diabetes

E-ISSN： 1875-5917|3|2|151-169

ISSN： 1568-0088

Source： Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol.3, Iss.2, 2003-06, pp. : 151-169

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Combination of glibenclamide–metformin HCl for the treatment of type 2 diabetes mellitus

By Lamos Elizabeth Mary Stein Stephanie Aleskow Davis Stephen N

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 17, 2012-12 ,pp. : 2545-2554

Informa Healthcare

Access to resources Recommend Favorite

Metformin extended release for the treatment of Type 2 diabetes mellitus

By Schwartz Sherwyn L Wu Jacqueline F Berner Bret

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 6, 2006-04 ,pp. : 803-809

Informa Healthcare

Access to resources Recommend Favorite

Metformin ++ saxagliptin for type 2 diabetes

By Scheen André J

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 1, 2012-01 ,pp. : 139-146

Informa Healthcare

Access to resources Recommend Favorite

Cost Effectiveness of Saxagliptin and Metformin versus Sulfonylurea and Metformin in the Treatment of Type 2 Diabetes Mellitus in Germany: A Cardiff Diabetes Model Analysis

By Erhardt Wilma

Clinical Drug Investigation, Vol. 32, Iss. 3, 2012-03 ,pp. : 189-202

Adis International

Access to resources Recommend Favorite

The Hot and Potential Targets of Type 2 Diabetes Mellitus Treatment in Recent Decade

Current Drug Targets, Vol. 19, Iss. 1, 2018-01 ,pp. : 55-69

Bentham Science Publishers

Access to resources Recommend Favorite